Matthew K. Szot serves as Director of SenesTech, Inc. (SNES). Szot has also held reporting roles at Cadrenal Therapeutics, Inc. (CVKD) and INVO Fertility, Inc. (IVF). Szot has reported 16 insider filings with the SEC since 2025. The most recent filing was in June 2026.
Every role Matthew K. Szot has reported on a Form 4, reconstructed from the filings themselves. Reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
Latest filing:
Matthew K. Szot is Director of SenesTech, Inc. (SNES). 11 SEC Form 4 filings on record going back to 2025, most recently on 17 June 2026. Most recent open-market trade: sold $69K of CVKD on 31 December 2025. Lifetime open-market sales: $397K.
Every recent SEC Form 4 transaction Matthew K. Szot has reported, most recent first.
InsiderAlpha's records for Matthew K. Szot go back to 2025: 11 primary Form 4 filings, an average of 5.5 per year. 6 recorded transactions carry a Rule 10b5-1 plan flag. This identifies the marked transactions as reported under a trading plan; it does not establish the plan status of unmarked transactions.
Insiders who reported open-market trades in the last 12 months at the companies Matthew K. Szot files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Matthew K. Szot is a corporate insider, tracked as Director of SenesTech, Inc. (SNES). InsiderAlpha holds 11 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
The most recent primary Form 4 on record is dated 17 June 2026, one of 11 filings going back to 2025.
Recorded transactions: 0 open-market purchases and 14 open-market sales ($397K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial